Joint trajectories of skeletal muscle and fat mass in relation to glucose homeostasis: 6-Year findings from adults aged ≥50 years.

IF 5.7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Qiao Xiang, Yuxiao Li, Gregory Y H Lip, Daniel J Cuthbertson, Wei Huang, Ziyi Zhong, Birong Dong, Jirong Yue, Masoud Isanejad
{"title":"Joint trajectories of skeletal muscle and fat mass in relation to glucose homeostasis: 6-Year findings from adults aged ≥50 years.","authors":"Qiao Xiang, Yuxiao Li, Gregory Y H Lip, Daniel J Cuthbertson, Wei Huang, Ziyi Zhong, Birong Dong, Jirong Yue, Masoud Isanejad","doi":"10.1111/dom.70113","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>We aimed to identify sex-specific joint skeletal muscle mass index (SMI)-fat mass index (FMI) trajectories and examine their associations with glucose homeostasis in adults aged ≥50 years.</p><p><strong>Materials and methods: </strong>We included 2323 community-dwelling adults from the West China Health and Aging Trend cohort. SMI and FMI were measured using bioelectrical impedance analysis. Glucose homeostasis was assessed via Homeostasis Model Assessment of insulin resistance (HOMA-IR) and Homeostasis Model Assessment of beta-cell function (HOMA-β). Sex-stratified group-based trajectory modelling identified joint SMI-FMI patterns, and their associations with glucose measures were evaluated using linear mixed-effects models. Sensitivity analyses were conducted using generalised estimating equations and by excluding participants with diabetes.</p><p><strong>Results: </strong>Five joint SMI-FMI trajectory classes (C0-C4) were identified per sex. Baseline HOMA-IR and HOMA-β were lowest in the normal-FMI C0/C4, intermediate in the overweight-FMI C1/C2 and highest in the obese-FMI C3, regardless of SMI. HOMA-IR increased significantly in high-FMI trajectories in both sexes (mean net annual increases: 2.63% for C2 and 2.55% for C3 in males; 1.65% for C2 and 2.62% for C3 in females) and also in female C0 with high SMI and normal FMI (mean net annual increases: 1.03%). HOMA-β remained stable over time in both sexes, with no significant between-class differences in its rate of change. Sensitivity analyses largely confirmed these findings.</p><p><strong>Conclusions: </strong>High-FMI trajectories were associated with elevated baseline insulin resistance (IR), enhanced compensatory β-cell function in both sexes and faster IR progression in males, while SMI offered limited protection. Females exhibited a broader decline in insulin sensitivity, whereas in males, this decline was primarily associated with high adiposity.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.70113","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: We aimed to identify sex-specific joint skeletal muscle mass index (SMI)-fat mass index (FMI) trajectories and examine their associations with glucose homeostasis in adults aged ≥50 years.

Materials and methods: We included 2323 community-dwelling adults from the West China Health and Aging Trend cohort. SMI and FMI were measured using bioelectrical impedance analysis. Glucose homeostasis was assessed via Homeostasis Model Assessment of insulin resistance (HOMA-IR) and Homeostasis Model Assessment of beta-cell function (HOMA-β). Sex-stratified group-based trajectory modelling identified joint SMI-FMI patterns, and their associations with glucose measures were evaluated using linear mixed-effects models. Sensitivity analyses were conducted using generalised estimating equations and by excluding participants with diabetes.

Results: Five joint SMI-FMI trajectory classes (C0-C4) were identified per sex. Baseline HOMA-IR and HOMA-β were lowest in the normal-FMI C0/C4, intermediate in the overweight-FMI C1/C2 and highest in the obese-FMI C3, regardless of SMI. HOMA-IR increased significantly in high-FMI trajectories in both sexes (mean net annual increases: 2.63% for C2 and 2.55% for C3 in males; 1.65% for C2 and 2.62% for C3 in females) and also in female C0 with high SMI and normal FMI (mean net annual increases: 1.03%). HOMA-β remained stable over time in both sexes, with no significant between-class differences in its rate of change. Sensitivity analyses largely confirmed these findings.

Conclusions: High-FMI trajectories were associated with elevated baseline insulin resistance (IR), enhanced compensatory β-cell function in both sexes and faster IR progression in males, while SMI offered limited protection. Females exhibited a broader decline in insulin sensitivity, whereas in males, this decline was primarily associated with high adiposity.

骨骼肌和脂肪量的关节轨迹与葡萄糖稳态的关系:来自年龄≥50岁成年人的6年研究结果
目的:我们旨在确定性别特异性的关节骨骼肌质量指数(SMI)-脂肪质量指数(FMI)轨迹,并研究它们与50岁以上成年人葡萄糖稳态的关系。材料和方法:我们纳入了来自中国西部健康和老龄化趋势队列的2323名社区居住成年人。采用生物电阻抗法测定SMI和FMI。葡萄糖稳态通过胰岛素抵抗稳态模型评估(HOMA- ir)和β细胞功能稳态模型评估(HOMA-β)进行评估。基于性别分层的群体轨迹模型确定了SMI-FMI联合模式,并使用线性混合效应模型评估了它们与血糖测量的关联。敏感性分析采用广义估计方程并排除糖尿病患者。结果:按性别确定了5个关节SMI-FMI轨迹类别(C0-C4)。基线HOMA- ir和HOMA-β在正常fmi C0/C4中最低,在超重fmi C1/C2中居中,在肥胖fmi C3中最高,与SMI无关。在高FMI轨迹中,HOMA-IR在两性中显著增加(男性C2和C3的平均年净增幅分别为2.63%和2.55%;女性C2和C3的平均年净增幅分别为1.65%和2.62%),在高SMI和正常FMI的女性C0中也显著增加(平均年净增幅为1.03%)。随着时间的推移,HOMA-β在两性中保持稳定,其变化率在班级之间没有显著差异。敏感性分析在很大程度上证实了这些发现。结论:高fmi轨迹与基线胰岛素抵抗(IR)升高、两性补偿性β细胞功能增强以及男性IR进展加快有关,而SMI提供的保护有限。女性表现出更广泛的胰岛素敏感性下降,而在男性中,这种下降主要与高肥胖有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信